Karen H. Costenbader

Rheumatology

60 Fenwood Rd
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 338 publications

Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis.

Prevalence and Clinical Relevance of Antiphospholipid Antibodies in Ischemic Stroke: A Systematic Review and Meta-Analysis.

Journal: Stroke

Published: August 28, 2026

Comparative Performance of SLECRISK and PREVENT for Cardiovascular Risk Prediction in Systemic Lupus Erythematosus.

Comparative Performance of SLECRISK and PREVENT for Cardiovascular Risk Prediction in Systemic Lupus Erythematosus.

Journal: The Journal of rheumatology

Published: August 01, 2026

Comparative Performance of SLECRISK and PREVENT for Cardiovascular Risk Prediction in Systemic Lupus Erythematosus.

Comparative Performance of SLECRISK and PREVENT for Cardiovascular Risk Prediction in Systemic Lupus Erythematosus.

Journal: The Journal of rheumatology

Published: August 01, 2026

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL-AF Study Design.

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL-AF Study Design.

Journal: Thrombosis and haemostasis

Published: June 25, 2026

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Journal: Thrombosis and haemostasis

Published: June 25, 2026

Electronic cigarette use and risk of incident rheumatoid arthritis and systemic lupus erythematosus in the all of us research program.

Electronic cigarette use and risk of incident rheumatoid arthritis and systemic lupus erythematosus in the all of us research program.

Journal: Seminars in arthritis and rheumatism

Published: June 22, 2026

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 08, 2026

Maternal weight and hypertension as risk factors for juvenile idiopathic arthritis: a prospective population-based pregnancy cohort study.

Maternal weight and hypertension as risk factors for juvenile idiopathic arthritis: a prospective population-based pregnancy cohort study.

Journal: RMD open

Published: March 13, 2026

Antiphospholipid antibodies and cardiovascular thrombosis.

Antiphospholipid antibodies and cardiovascular thrombosis.

Journal: Nature reviews. Cardiology

Published: February 16, 2026

SIGLEC-1 Expression in a Cohort of Patients With Lupus Erythematosus Treated With Anifrolumab.

SIGLEC-1 Expression in a Cohort of Patients With Lupus Erythematosus Treated With Anifrolumab.

Journal: JAMA dermatology

Published: February 11, 2026

Opioid Use Disorder and Treatment Uptake Among Patients With Rheumatic Conditions in the All of Us Research Program: A Descriptive Analysis.

Opioid Use Disorder and Treatment Uptake Among Patients With Rheumatic Conditions in the All of Us Research Program: A Descriptive Analysis.

Journal: Arthritis care & research

Published: February 03, 2026

Cardiometabolic protective mechanisms and efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in SLE.

Cardiometabolic protective mechanisms and efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in SLE.

Journal: Rheumatology (Oxford, England)

Published: February 02, 2026

Showing 1-12 of 338

Last Updated: 09/26/2026